Equity

9 Months Ended

Sep. 30, 2025

Stockholders' Equity Note [Abstract]

Equity

Note 5 - Equity

Common Stock

The Company has 250,000,000, $0.0001 par value shares of voting common stock authorized.

During the nine months ended September 30, 2025, there were no issuances of common stock.

On September 10, the Company filed a change in the article of incorporation and increased the voting common stock authorized from 75,000,000 to 250,000,000. In addition, the Company completed a 1 for 4 reverse common stock split, decreasing the number of voting common stock outstanding from 43,916,221 to 10,979,055. These financial statements have been retroactively adjusted for all periods presented.

During the three months ended September 30, 2024, the Company issued 125,000 shares of common stock for cash proceeds of $175,000.

During the three months ended March 31, 2024, the Company issued 175,000 shares of common stock for cash proceeds of $175,000.

As of September 30, 2025 and December 31, 2024, the Company had 10,979,055 shares of common stock issued and outstanding, respectively.

Preferred Stock

On October 19, 2021, the Company filed a Certificate of Amendment to its Articles of Incorporation authorizing up to 5,000,000 shares of Preferred Stock, par value $0.0001 per share, with such rights, preferences and limitations as may be set forth in resolutions adopted by the Board of Directors. On November 1, 2021, the Company filed a Certificate of Designation designating 1,000,000 shares of Preferred Stock as Series A Convertible Preferred Stock (the “Series A”). Each share of the Series A is convertible into three shares of the Company’s common stock at the holder’s election, subject to a 4.99% beneficial ownership limitation which may be increased to 9.99% upon 61 days’ notice.

During the nine months ended September 30, 2025 and 2024 there were no issuances of preferred stock. As of September 30, 2025 and December 31, 2024, the Company had 140,000 shares of Series A Convertible Preferred Stock outstanding.